Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subclinical Cardiovascular Disease in Psoriatic Disease

NCT03228017 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03228017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03228017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subclinical Cardiovascular Disease in Psoriatic Disease
Lead sponsor
NYU Langone Health
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2017
Completion date
April 1, 2019
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease, cardiovascular diseases, myocardial infarction, thrombotic vascular disease